Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 71 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Protagenic Therapeutics Inc | PTIXW | NASDAQ | Equity Warrant |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.004 | 16:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0045 | 0.0045 | 0.0045 | 0.004 | 0.004 |
| Trades | Shares Traded | Average Volume |
|---|---|---|
| 7 | 71 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 9 | 0.0045 | USD |
Protagenic Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 17.74k | 4.44M | - | 0 | -5M | -1.13 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Protagenic Therapeutics
| Date | Time | Source | Heading |
|---|---|---|---|
| 2/14/2025 | 16:06 | Edgar (US Regulatory) | Form SCHEDULE 13G/A - Statement of Beneficial Ownership by.. |
| 1/29/2025 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/10/2025 | 05:04 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/10/2025 | 05:02 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 1/07/2025 | 10:14 | Edgar (US Regulatory) | Form S-3/A - Registration statement under Securities Act of.. |
| 1/06/2025 | 16:22 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 1/03/2025 | 16:03 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 12/27/2024 | 15:00 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 12/20/2024 | 05:12 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
| 12/19/2024 | 05:24 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 12/03/2024 | 06:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/22/2024 | 15:12 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
PTIXW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. |
NASDAQ:PTIXW -
What is the current Protagenic Therapeutics Inc share price?
The current share price of Protagenic Therapeutics Inc is US$ 0.004
How many Protagenic Therapeutics Inc shares are in issue?
Protagenic Therapeutics Inc has 4,435,000 shares in issue
What is the market cap of Protagenic Therapeutics Inc?
The market capitalisation of Protagenic Therapeutics Inc is USD 17.74k
What is the 1 year trading range for Protagenic Therapeutics Inc share price?
Protagenic Therapeutics Inc has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Protagenic Therapeutics Inc?
The price to earnings ratio of Protagenic Therapeutics Inc is -0.22
What is the reporting currency for Protagenic Therapeutics Inc?
Protagenic Therapeutics Inc reports financial results in USD
What is the latest annual profit for Protagenic Therapeutics Inc?
The latest annual profit of Protagenic Therapeutics Inc is USD -5M
What is the registered address of Protagenic Therapeutics Inc?
The registered address for Protagenic Therapeutics Inc is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Protagenic Therapeutics Inc website address?
The website address for Protagenic Therapeutics Inc is www.protagenic.com
Which industry sector does Protagenic Therapeutics Inc operate in?
Protagenic Therapeutics Inc operates in the BOOKS: PUBG, PUBG & PRINTING sector
